Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes -- Wen et al. 179 (12): 1263 Data Supplement - Online Appendices -- Canadian Medical Association Journal

© 2008 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes
CMAJ Wen et al. 179: 1263

Online Appendices

Files in this Data Supplement:

Appendix 1: Distribution of dispensation of folic acid antagonists Saskatchewan, 1980–2000, subdivided as early, middle, and late
Appendix 2: Risk of adverse pregnancy outcomes associated with degree of exposure to folic acid antagonists (in terms of number of tablets or capsules) in Saskatchewan, 1980–2000
Appendix 3: Results of sensitivity analyses of the association between maternal exposure to folic acid antagonists and adverse pregnancy outcomes in Saskatchewan, 1980-2000